PER-064-20招募中未知
BOVINE LACTOFERRIN FOR THE PREVENTION OF COVID-19 INFECTION IN PHYSICIANS AND NURSES IN HOSPITALS IN LIMA, PERU: A DOUBLE BLINDED RANDOMIZED CLINICAL TRIA
IVERSIDAD PERUANA CAYETANO HEREDIA,0 个研究点目标入组 209 人开始时间: 2020年9月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 209
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.- Man or woman over 18 and under 60 years old.
- •2.- Physicians or nurses who work in areas of care for patients with COVID-19 (emergency, hospitalization, and ICU) in hospitals in Lima, Peru.
- •3.- Healthy participants, without COVID-19 suggestive symptoms.
- •4.- Participant who wants to participate and signs the informed consent.
排除标准
- •1.- Participant who had a previous diagnosis of COVID-19.
- •2.- Participant positive in the initial screening for IgM or IgG positive RT-PCR for COVID-19.
- •3.- Participant with the following comorbidities: hypertension, coronary heart disease, diabetes mellitus, obesity, chronic lung disease, cancer, kidney failure, or other hematological /and immunosuppressive diseases.
- •4.- Pregnant woman.
- •5.- Participant that are part of another clinical trial or is receiving any supplement or preventive treatment for COVID 19.
- •6.- Participant with known allergy to cow´s milk protein.
研究者
相似试验
尚未招募
不适用
Will colchicine be useful as an agent to prevent SARS-CoV-2 infection in kidney failure patients who are on maintenance hemodialysis?CTRI/2021/05/033605CMC Fluid research Funding
已完成
2 期
Bovine Lactoferrin and Antibiotic-associated Diarrhoea.Antibiotic Associated DiarrhoeaNCT02626104Medical University of Warsaw156
Unknown
2 期
Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19COVID-19NCT04421534Cairo University150
已完成
2 期
Pilot Study: Lactoferrin for Prevention of Neonatal SepsisSepsisNCT01264536Universidad Peruana Cayetano Heredia190
终止
2 期
Lactoferrin for Prevention of COVID-19 in Health Care WorkersSARS-CoV-2NCT04526821Universidad Peruana Cayetano Heredia209